Asuragen Inc-Product Pipeline Analysis, 2017 Update

Asuragen Inc-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME6095PD
  • |
  • Pages: 29
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Asuragen Inc (Asuragen) is a provider of laboratory medicine solutions. The company offers products which include amplidex, quantidex, and custom reagents. It offers custom and companion diagnostic services which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. The company's custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It distributes its products in Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US, among others. Asuragen is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Asuragen Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Asuragen Inc Company Overview 4

Asuragen Inc Company Snapshot 4

Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Asuragen Inc-Pipeline Analysis Overview 7

Asuragen Inc-Key Facts 7

Asuragen Inc-Major Products and Services 8

Asuragen Inc Pipeline Products by Development Stage 9

Asuragen Inc Pipeline Products Overview 11

Diagnostic Test-Neurodegenerative Disorders 11

Diagnostic Test-Neurodegenerative Disorders Product Overview 11

miRNA Based Sequencing Test- Esophageal Cancer 12

miRNA Based Sequencing Test- Esophageal Cancer Product Overview 12

miRNA Based Sequencing Test-Colon Cancer 13

miRNA Based Sequencing Test-Colon Cancer Product Overview 13

miRNA Based Sequencing Test-Lung Cancer 14

miRNA Based Sequencing Test-Lung Cancer Product Overview 14

miRNA Based Sequencing Test-Pancreatic Cancer 15

miRNA Based Sequencing Test-Pancreatic Cancer Product Overview 15

Signature CF Expand 16

Signature CF Expand Product Overview 16

Asuragen Inc-Key Competitors 17

Asuragen Inc-Key Employees 18

Asuragen Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Asuragen Inc, Recent Developments 20

Apr 25, 2017: Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio 20

Mar 14, 2017: Asuragen Launches the AmplideX PCR/CE TOMM40 Kit Expanding Portfolio into the Alzheimer's and Cognitive Impairment Space 20

Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit 20

Aug 09, 2016: Asuragen Develops Armored RNA Quant Zika Virus Control 21

Jul 25, 2016: Asuragen's QuantideX qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance For Monitoring Minimal Residual Disease In Chronic Myeloid Leukemia 22

Jul 06, 2016: Asuragen Launches the AmplideX PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia 22

Apr 18, 2016: Asuragen to Present Expansion of Next-Generation Sequencing Portfolio at American Association for Cancer Research Annual Meeting 23

Nov 05, 2015: Asuragen Launches Amplidex PCR/CE FMR1 Reporter, A Fully Automated Software Solution For Accurate Sizing Of The FMR1 CGG Repeat Region 23

Jul 08, 2015: Asuragen Launches the Quantidex Pan Cancer Kit, a Workflow Solution for Targeted Next-Generation Sequencing 24

Jun 11, 2015: Asuragen Announces Launch of Highly Sensitive CE-IVD BCR-ABL Assay at the European Hematology Association Annual Congress 25

Appendix 26

Methodology 26

About GlobalData 28

Contact Us 28

Disclaimer 28

List of Figures

Asuragen Inc Pipeline Products by Equipment Type 5

Asuragen Inc Pipeline Products by Development Stage 9

List of Tables

Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Asuragen Inc Pipeline Products by Equipment Type 5

Asuragen Inc Pipeline Products by Indication 6

Asuragen Inc, Key Facts 7

Asuragen Inc, Major Products and Services 8

Asuragen Inc Number of Pipeline Products by Development Stage 9

Asuragen Inc Pipeline Products Summary by Development Stage 10

Diagnostic Test-Neurodegenerative Disorders-Product Status 11

Diagnostic Test-Neurodegenerative Disorders-Product Description 11

miRNA Based Sequencing Test- Esophageal Cancer-Product Status 12

miRNA Based Sequencing Test- Esophageal Cancer-Product Description 12

miRNA Based Sequencing Test-Colon Cancer-Product Status 13

miRNA Based Sequencing Test-Colon Cancer-Product Description 13

miRNA Based Sequencing Test-Lung Cancer-Product Status 14

miRNA Based Sequencing Test-Lung Cancer-Product Description 14

miRNA Based Sequencing Test-Pancreatic Cancer-Product Status 15

miRNA Based Sequencing Test-Pancreatic Cancer-Product Description 15

Signature CF Expand-Product Status 16

Signature CF Expand-Product Description 16

Asuragen Inc, Key Employees 18

Glossary 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Asuragen Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 52500
Site License
USD 1500 INR 105000
Corporate User License
USD 2250 INR 157500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com